Ty J Schoelerman, John P Hutcheson, Lee-Anne J Walter, Wade T Nichols, Ben P Holland, Alyssa B Word
{"title":"4种不同的种植方案对本地轻质肉牛的饲料性能、健康和胴体特性的影响","authors":"Ty J Schoelerman, John P Hutcheson, Lee-Anne J Walter, Wade T Nichols, Ben P Holland, Alyssa B Word","doi":"10.1093/jas/skaf102.242","DOIUrl":null,"url":null,"abstract":"Due to new reimplant restrictions, delaying implant administration after arrival could prevent inadequate implant coverage at the end of the feeding period. Therefore, the objectives of this study were to determine the effects of a traditional reimplant program [Synovex Choice (100 mg trenbolone acetate and 14 mg estradiol benzoate) on arrival reimplanted at 110 days with Synovex Plus (200 mg trenbolone acetate and 28 mg estradiol benzoate) (CHPL)] relative to an extended release implant [Revalor XH (200 mg trenbolone acetate and 20 mg estradiol) (XH)] administered on arrival (XH0) or delayed 40 (XH40) or 80 d (XH80) to determine an ideal implant window in heifers fed 219 d. A total of 2,800 heifers (initial BW = 254 ± 27.24 kg.) were enrolled, blocked by time of arrival and randomized to treatment. Dry matter intake was reduced (P = 0.02) in XH80 heifers, greatest in XH0 and CHPL heifers with XH40 heifers not different. There were no differences in final BW, ADG or G:F between treatments (P ≥ 0.12). Hot carcass weight did not differ (P ≥ 0.19) between treatments, whereas ribeye area was greater (P = 0.02) when heifers were administered XH40 (83.42 cm2) or CHPL (83.35 cm2) vs XH80 (81.61 cm2); XH0 (82.64 cm2) did not differ from other treatments. Implant treatment did not affect backfat and EBF (P ≥ 0.10); however, marbling score was lower (P = 0.04) for CHPL (455) heifers vs. XH80 (478) while XH0 (470) and XH40 (459) were not different than other treatments. Percentage of carcasses grading USDA Prime was greatest (P < 0.01) for XH80 (5.78%), vs XH0 (2.55%) and CHPL (2.72%). Percentage of carcasses grading Choice was also reduced (P = 0.05) for CHPL (65.89%) compared to all other treatments (76.11, 71.94 and 74.84% for XH0, XH40 and XH80, respectively). Conversely, the percentage of carcasses grading Select was greatest (P < 0.01) for CHPL compared to all XH treatments. There were no differences among treatments in percentage of carcasses classified YG 1, 3, or 5 (P ≥ 0.20). However, percentage of carcasses classified YG2 was greatest (P = 0.02) in CHPL (31.74%), least in XH0 (24.95%) and XH40 (26.83%), with XH80 (27.39%) not different than other treatments. Percentage of carcasses classified YG4 was greater (P = 0.01) for XH80 (25.74%) and XH0 (24.68%) compared to CHPL (19.21%) and XH40 (19.58%). Revalor-XH on arrival or delayed 40, or 80d did not affect live growth performance of heifers, although DMI was reduced when Revalor-XH was administered on day 80. A reimplant program of Synovex Choice followed by Synovex Plus did not affect live performance or HCW but resulted in leaner carcasses and reduced quality grade compared to an on-arrival or delayed administration of Revalor-XH.","PeriodicalId":14895,"journal":{"name":"Journal of animal science","volume":"2 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"120 The effect of four different implant programs on feedyard performance, health, and carcass characteristics of native light weight beef heifers\",\"authors\":\"Ty J Schoelerman, John P Hutcheson, Lee-Anne J Walter, Wade T Nichols, Ben P Holland, Alyssa B Word\",\"doi\":\"10.1093/jas/skaf102.242\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Due to new reimplant restrictions, delaying implant administration after arrival could prevent inadequate implant coverage at the end of the feeding period. Therefore, the objectives of this study were to determine the effects of a traditional reimplant program [Synovex Choice (100 mg trenbolone acetate and 14 mg estradiol benzoate) on arrival reimplanted at 110 days with Synovex Plus (200 mg trenbolone acetate and 28 mg estradiol benzoate) (CHPL)] relative to an extended release implant [Revalor XH (200 mg trenbolone acetate and 20 mg estradiol) (XH)] administered on arrival (XH0) or delayed 40 (XH40) or 80 d (XH80) to determine an ideal implant window in heifers fed 219 d. A total of 2,800 heifers (initial BW = 254 ± 27.24 kg.) were enrolled, blocked by time of arrival and randomized to treatment. Dry matter intake was reduced (P = 0.02) in XH80 heifers, greatest in XH0 and CHPL heifers with XH40 heifers not different. There were no differences in final BW, ADG or G:F between treatments (P ≥ 0.12). Hot carcass weight did not differ (P ≥ 0.19) between treatments, whereas ribeye area was greater (P = 0.02) when heifers were administered XH40 (83.42 cm2) or CHPL (83.35 cm2) vs XH80 (81.61 cm2); XH0 (82.64 cm2) did not differ from other treatments. Implant treatment did not affect backfat and EBF (P ≥ 0.10); however, marbling score was lower (P = 0.04) for CHPL (455) heifers vs. XH80 (478) while XH0 (470) and XH40 (459) were not different than other treatments. Percentage of carcasses grading USDA Prime was greatest (P < 0.01) for XH80 (5.78%), vs XH0 (2.55%) and CHPL (2.72%). Percentage of carcasses grading Choice was also reduced (P = 0.05) for CHPL (65.89%) compared to all other treatments (76.11, 71.94 and 74.84% for XH0, XH40 and XH80, respectively). Conversely, the percentage of carcasses grading Select was greatest (P < 0.01) for CHPL compared to all XH treatments. There were no differences among treatments in percentage of carcasses classified YG 1, 3, or 5 (P ≥ 0.20). However, percentage of carcasses classified YG2 was greatest (P = 0.02) in CHPL (31.74%), least in XH0 (24.95%) and XH40 (26.83%), with XH80 (27.39%) not different than other treatments. Percentage of carcasses classified YG4 was greater (P = 0.01) for XH80 (25.74%) and XH0 (24.68%) compared to CHPL (19.21%) and XH40 (19.58%). Revalor-XH on arrival or delayed 40, or 80d did not affect live growth performance of heifers, although DMI was reduced when Revalor-XH was administered on day 80. A reimplant program of Synovex Choice followed by Synovex Plus did not affect live performance or HCW but resulted in leaner carcasses and reduced quality grade compared to an on-arrival or delayed administration of Revalor-XH.\",\"PeriodicalId\":14895,\"journal\":{\"name\":\"Journal of animal science\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of animal science\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.1093/jas/skaf102.242\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"AGRICULTURE, DAIRY & ANIMAL SCIENCE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of animal science","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1093/jas/skaf102.242","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"AGRICULTURE, DAIRY & ANIMAL SCIENCE","Score":null,"Total":0}
120 The effect of four different implant programs on feedyard performance, health, and carcass characteristics of native light weight beef heifers
Due to new reimplant restrictions, delaying implant administration after arrival could prevent inadequate implant coverage at the end of the feeding period. Therefore, the objectives of this study were to determine the effects of a traditional reimplant program [Synovex Choice (100 mg trenbolone acetate and 14 mg estradiol benzoate) on arrival reimplanted at 110 days with Synovex Plus (200 mg trenbolone acetate and 28 mg estradiol benzoate) (CHPL)] relative to an extended release implant [Revalor XH (200 mg trenbolone acetate and 20 mg estradiol) (XH)] administered on arrival (XH0) or delayed 40 (XH40) or 80 d (XH80) to determine an ideal implant window in heifers fed 219 d. A total of 2,800 heifers (initial BW = 254 ± 27.24 kg.) were enrolled, blocked by time of arrival and randomized to treatment. Dry matter intake was reduced (P = 0.02) in XH80 heifers, greatest in XH0 and CHPL heifers with XH40 heifers not different. There were no differences in final BW, ADG or G:F between treatments (P ≥ 0.12). Hot carcass weight did not differ (P ≥ 0.19) between treatments, whereas ribeye area was greater (P = 0.02) when heifers were administered XH40 (83.42 cm2) or CHPL (83.35 cm2) vs XH80 (81.61 cm2); XH0 (82.64 cm2) did not differ from other treatments. Implant treatment did not affect backfat and EBF (P ≥ 0.10); however, marbling score was lower (P = 0.04) for CHPL (455) heifers vs. XH80 (478) while XH0 (470) and XH40 (459) were not different than other treatments. Percentage of carcasses grading USDA Prime was greatest (P < 0.01) for XH80 (5.78%), vs XH0 (2.55%) and CHPL (2.72%). Percentage of carcasses grading Choice was also reduced (P = 0.05) for CHPL (65.89%) compared to all other treatments (76.11, 71.94 and 74.84% for XH0, XH40 and XH80, respectively). Conversely, the percentage of carcasses grading Select was greatest (P < 0.01) for CHPL compared to all XH treatments. There were no differences among treatments in percentage of carcasses classified YG 1, 3, or 5 (P ≥ 0.20). However, percentage of carcasses classified YG2 was greatest (P = 0.02) in CHPL (31.74%), least in XH0 (24.95%) and XH40 (26.83%), with XH80 (27.39%) not different than other treatments. Percentage of carcasses classified YG4 was greater (P = 0.01) for XH80 (25.74%) and XH0 (24.68%) compared to CHPL (19.21%) and XH40 (19.58%). Revalor-XH on arrival or delayed 40, or 80d did not affect live growth performance of heifers, although DMI was reduced when Revalor-XH was administered on day 80. A reimplant program of Synovex Choice followed by Synovex Plus did not affect live performance or HCW but resulted in leaner carcasses and reduced quality grade compared to an on-arrival or delayed administration of Revalor-XH.
期刊介绍:
The Journal of Animal Science (JAS) is the premier journal for animal science and serves as the leading source of new knowledge and perspective in this area. JAS publishes more than 500 fully reviewed research articles, invited reviews, technical notes, and letters to the editor each year.
Articles published in JAS encompass a broad range of research topics in animal production and fundamental aspects of genetics, nutrition, physiology, and preparation and utilization of animal products. Articles typically report research with beef cattle, companion animals, goats, horses, pigs, and sheep; however, studies involving other farm animals, aquatic and wildlife species, and laboratory animal species that address fundamental questions related to livestock and companion animal biology will be considered for publication.